Doughty Brian 4
4 · CARDIOVASCULAR SYSTEMS INC · Filed Feb 27, 2009
Insider Transaction Report
Form 4
Doughty Brian
VP of Marketing
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2009-02-25−70,000→ 0 total→ Common Stock (70,000 underlying) - Disposition to Issuer
Common Stock
2009-02-25−4,900→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−5,000→ 0 total→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−25,000→ 0 total→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−10,000→ 0 total→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−50,000→ 0 total→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to a merger agreement among the issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each share of the issuer's common stock was converted into 0.647 shares of common stock of Replidyne, Inc.
- [F2]Disposed of pursuant to a merger agreement among issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each of the issuer's stock options was assumed by Replidyne, Inc. and became exercisable to purchase shares of Replidyne, Inc. common stock; each share covered by the issuer's options was converted into 0.647 shares of common stock of Replidyne, Inc., and the exercise price of each option was adjusted by dividing the pre-merger exercise price by 0.647 and rounding up to the nearest cent.